RET and colorectal cancer: Although the identification of gain-of-function RET mutations have been described in colorectal cancer (21), the clinical significance of RET mutations detected in our cohort is currently unknown, with the exception of variant G691S, detected in 3 cases, which has been reported associated to increased invasion in cultured cells (22).